Scorpion Biological Services to create new Kansas biomanufacturing facility
CDMO Scorpion Biological Services will build a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.
Archives for April 26, 2022
Valneva and Pfizer report positive Phase 2 data for Lyme disease vaccine in children
Valneva and Pfizer report positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15: and now plan to include this population in an upcoming Phase 3 trial.